Crosslee’s research focuses on integrating multiOMICs (proteomics, transcriptomics and metabolomics) analysis of biopsy tissues to better understand the spatial distribution of molecular networks and the cell-cell communications underlying disease pathology. These studies can not only uncover novel biomarkers for diagnostics with high sensitivity and specificity but can also be investigated for their pathogenicity and role in disease progression and serve as therapeutic targets for the development of next generation of targeted therapeutics